Cargando…
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
PURPOSE: Triple-negative breast cancer (TNBC) is phenotypic of breast tumors lacking expression of the estrogen receptor (ER), the progesterone receptor (PgR), and the human epidermal growth factor receptor 2 (HER2). The paucity of well-defined molecular targets in TNBC, coupled with the increasing...
Autores principales: | Mungra, Neelakshi, Biteghe, Fleury A. N., Malindi, Zaria, Huysamen, Allan M., Karaan, Maryam, Hardcastle, Natasha S., Bunjun, Rubina, Chetty, Shivan, Naran, Krupa, Lang, Dirk, Richter, Wolfgang, Hunter, Roger, Barth, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465649/ https://www.ncbi.nlm.nih.gov/pubmed/37432459 http://dx.doi.org/10.1007/s00432-023-05031-3 |
Ejemplares similares
-
Click Chemistry-Generated
Auristatin F–Linker–Benzylguanine
for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating
Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
por: Huysamen, Allan M., et al.
Publicado: (2023) -
CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL
por: Jordaan, Sandra, et al.
Publicado: (2017) -
Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
por: Mungra, Neelakshi, et al.
Publicado: (2019) -
Recent advances in immunotherapies against infectious diseases
por: Ramamurthy, Dharanidharan, et al.
Publicado: (2020) -
Applications of SNAP‐tag technology in skin cancer therapy
por: Padayachee, Eden Rebecca, et al.
Publicado: (2019)